Similar articles

• [Influence of a new oral hypoglycemic product (glibenclamide-phenformin) on some aspects of lipid metabolism].

  Ceruso D, Squadrito G, Emanuele M, Quartarone M, Bellinghieri G. Ceruso D, et al. Boll Soc Ital Biol Sper. 1973 Nov 30;49(22):1285-9. Boll Soc Ital Biol Sper. 1973. PMID: 4212680 Italian. No abstract available.
• [Controlled clinical study of the therapeutic action of 2 combinations of glibenclamide and phenformin].

  Mascetti P, Mascetti R, Sampietro M. Mascetti P, et al. Clin Ter. 1978 Aug 15;86(3):263-75. Clin Ter. 1978. PMID: 105830 Italian. No abstract available.
• [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].

  Polosa P, Mughini L. Polosa P, et al. Minerva Med. 1974 Aug 29;65(59):383-9. Minerva Med. 1974. PMID: 4213556 Italian. No abstract available.
• [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].

  Tattersall RB. Tattersall RB. Journ Annu Diabetol Hotel Dieu. 1984:183-91. Journ Annu Diabetol Hotel Dieu. 1984. PMID: 6443219 Review. French. No abstract available.
• [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].

  Lunetta M, Presti C, Mughini MT, Mughini L. Lunetta M, et al. Clin Ter. 1980 Jun 30;93(6):657-72. Clin Ter. 1980. PMID: 6775864 Review. Italian. No abstract available.